MRK vs ABBV
MRK and ABBV side by side — valuation & fundamentals (public data).
Key statistics
| Metric | MRKMerck & Co., Inc. | ABBVAbbVie Inc. |
|---|---|---|
| Market cap | $366.23B | $510.38B |
| P/E (TTM) | 118.8 | 81.6 |
| P/B | 8.73 | — |
| P/S | 5.6x | 8.3x |
| Dividend yield | 2.23% | 2.28% |
| Revenue | $66.57B(TTM) | $61.16B(TTM) |
| Revenue growth (YoY) | 1.3% | 8.6% |
| Net income | $3.17B(TTM) | $6.31B(TTM) |
| Earnings growth (YoY) | 6.6% | -1.2% |
| EPS, diluted | $1.25(TTM) | $3.54(TTM) |
| EBIT margin | 34.2% | 24.6% |
| ROE | 43.5% | — |
| ROIC | 21.6% | 18.6% |
| 1y total return | +76.3% | +35.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: MRK frente a ABBV
| Métrica | MRK | ABBV |
|---|---|---|
| Valor final | $35.2K | $71.4K |
| Retorno total | +252.0% | +613.9% |
| CAGR | +12.9% | +20.9% |
| Volatilidad | 23.4% | 25.8% |
| Sharpe | 0.46 | 0.71 |
| Sortino | 0.67 | 0.99 |
| Caída máxima | -43.4% | -45.1% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.21% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)